AU510138B2 - Carbostyril derivatives - Google Patents

Carbostyril derivatives

Info

Publication number
AU510138B2
AU510138B2 AU36866/78A AU3686678A AU510138B2 AU 510138 B2 AU510138 B2 AU 510138B2 AU 36866/78 A AU36866/78 A AU 36866/78A AU 3686678 A AU3686678 A AU 3686678A AU 510138 B2 AU510138 B2 AU 510138B2
Authority
AU
Australia
Prior art keywords
group
crystals
colorless
needle
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU36866/78A
Other languages
English (en)
Other versions
AU3686678A (en
Inventor
T. Ueda H and Nakagawa K Nishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU3686678A publication Critical patent/AU3686678A/en
Application granted granted Critical
Publication of AU510138B2 publication Critical patent/AU510138B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
AU36866/78A 1977-06-10 1978-06-06 Carbostyril derivatives Expired AU510138B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JPJP62,319/7 1977-06-10
JPJP75,863/7 1977-06-24
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体
JPJP23,012/7 1978-02-28

Publications (2)

Publication Number Publication Date
AU3686678A AU3686678A (en) 1979-12-13
AU510138B2 true AU510138B2 (en) 1980-06-12

Family

ID=27284068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36866/78A Expired AU510138B2 (en) 1977-06-10 1978-06-06 Carbostyril derivatives

Country Status (21)

Country Link
US (1) US4298739A (enExample)
AR (2) AR224345A1 (enExample)
AT (1) AT367038B (enExample)
AU (1) AU510138B2 (enExample)
CA (1) CA1098907A (enExample)
CH (1) CH636087A5 (enExample)
DE (1) DE2825048A1 (enExample)
DK (1) DK149449C (enExample)
ES (2) ES470690A1 (enExample)
FI (1) FI69300C (enExample)
FR (1) FR2393795B1 (enExample)
GB (1) GB2002745B (enExample)
IE (1) IE46852B1 (enExample)
IT (1) IT1108326B (enExample)
MX (1) MX5527E (enExample)
NL (1) NL178074C (enExample)
NO (1) NO148813C (enExample)
NZ (1) NZ187452A (enExample)
PH (1) PH14670A (enExample)
PT (1) PT68157A (enExample)
SE (1) SE444562B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
FI80022C (fi) * 1982-07-05 1990-04-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat.
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
CA1254557A (en) * 1984-02-15 1989-05-23 Michael C. Venuti (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b) quinazolinyl) oxyalkylamides
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
TW201305B (enExample) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
CA2093633A1 (en) * 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
EP2196453A1 (en) * 2008-12-10 2010-06-16 Cellvir Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
WO2011021676A1 (ja) 2009-08-21 2011-02-24 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン-2,4-ジオン化合物の製造方法
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (enExample) * 1972-12-14 1977-10-03
JPS5234629B2 (enExample) * 1973-02-03 1977-09-05
NL179275C (nl) * 1973-10-24 1986-08-18 Otsuka Pharma Co Ltd Werkwijze voor de bereiding van farmacologisch werkzame glycerol-derivaten en werkwijze voor de bereiding van preparaten die ze bevatten.
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
NO148813B (no) 1983-09-12
GB2002745A (en) 1979-02-28
FI69300C (fi) 1986-01-10
PT68157A (en) 1978-07-01
ES470690A1 (es) 1979-10-16
NZ187452A (en) 1980-05-27
DE2825048C2 (enExample) 1991-05-08
SE7806710L (sv) 1978-12-11
PH14670A (en) 1981-10-30
IT1108326B (it) 1985-12-09
ES479138A1 (es) 1979-07-01
AU3686678A (en) 1979-12-13
SE444562B (sv) 1986-04-21
NL178074C (nl) 1986-01-16
ATA421378A (de) 1981-10-15
AT367038B (de) 1982-05-25
IE46852B1 (en) 1983-10-05
NO782022L (no) 1978-12-12
CA1098907A (en) 1981-04-07
DK254878A (da) 1979-02-09
FI69300B (fi) 1985-09-30
AR224345A1 (es) 1981-11-30
IE781104L (en) 1978-12-10
FI781811A7 (fi) 1978-12-11
IT7868355A0 (it) 1978-06-09
US4298739A (en) 1981-11-03
NO148813C (no) 1983-12-21
DK149449B (da) 1986-06-16
FR2393795A1 (fr) 1979-01-05
NL7806245A (nl) 1978-12-12
DE2825048A1 (de) 1978-12-14
DK149449C (da) 1986-11-24
FR2393795B1 (fr) 1986-07-25
MX5527E (es) 1983-09-23
GB2002745B (en) 1982-02-17
AR225755A1 (es) 1982-04-30
CH636087A5 (de) 1983-05-13

Similar Documents

Publication Publication Date Title
AU522716B2 (en) Acylanilide derivatives
AU524339B2 (en) Tripherylalkene derivatives
AU518216B2 (en) Thienothiazine derivatives
AU3686678A (en) Carbostyril derivatives
AU541144B2 (en) Aminoalkylbenzene derivatives
AU531493B2 (en) Thiohydantion derivatives
AU512266B2 (en) M-trifluoromethylphenylpiperazine derivatives
AU523183B2 (en) Ethoxygquin derivatives
AU515458B2 (en) Antioestrogenic phenylbut-1-ene derivatives
AU512057B2 (en) Meta-sulfonamido-benzamide derivatives
AU507066B1 (en) 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
AU517670B2 (en) Quinoline derivatives
AU516318B2 (en) 4-aminoquinoline derivatives
AU513950B2 (en) Carbostyril derivatives
AU515104B2 (en) Oxadiazolopyrimidine derivatives
AU520334B2 (en) 25-alkylcholesterol derivatives
AU502293B1 (en) 4-amino-oleandomycin derivatives
AU519005B2 (en) Phenylacycloakane derivatives
AU521883B2 (en) Pyranochromone derivatives
AU511994B2 (en) 7a-Methoxycephalosporins
AU517387B2 (en) Tetracyclononane derivatives
AU516948B2 (en) Fortimicing derivatives
AU516891B2 (en) Pregn-4-ene derivatives
ZA783202B (en) Novel carbostyril derivatives
AU513411B2 (en) Oxadiazolopyrimidine derivatives